Serious side effects include infections inside of the eye, cataracts, and detached retinas that may cause:
Some patients have had increased eye pressure before and within 1 hour of an injection.
Contact or visit your doctor if you experience the symptoms above.
Uncommonly, LUCENTIS patients have had serious, sometimes fatal, problems related to blood clots, such as heart attacks or strokes. Although there were only few fatal events which included causes of death typical of patients with advanced diabetic complications, these events may be caused by LUCENTIS.
LUCENTIS [package insert]. South San Francisco, CA: Genentech, Inc; 2018.
LUCENTIS [package insert]. South San Francisco, CA: Genentech, Inc; 2018.
Rosenfeld PJ, et al; MARINA Study Group. N Engl J Med. 2006;355:1419-1431.
Rosenfeld PJ, et al; MARINA Study Group. N Engl J Med. 2006;355:1419-1431.
Brown DM, et al; ANCHOR Study Group. Ophthalmology. 2009;116:57-65.
Brown DM, et al; ANCHOR Study Group. Ophthalmology. 2009;116:57-65.
Data on file. South San Francisco, CA: Genentech, Inc.
Data on file. South San Francisco, CA: Genentech, Inc.
Busbee BG, et al; HARBOR Study Group. Ophthalmology. 2013;120:1046-1056.
Busbee BG, et al; HARBOR Study Group. Ophthalmology. 2013;120:1046-1056.
Ho AC, et al; HARBOR Study Group. Ophthalmology. 2014;121:2181-2192.
Ho AC, et al; HARBOR Study Group. Ophthalmology. 2014;121:2181-2192.
Sarraf D, et al. Ophthalmology. 2016;123(10):2213-2224.
Sarraf D, et al. Ophthalmology. 2016;123(10):2213-2224.
Heier JS, et al; VIEW 1 and VIEW 2 Study Groups. Ophthalmology. 2012;119(12):2537-2548.
Heier JS, et al; VIEW 1 and VIEW 2 Study Groups. Ophthalmology. 2012;119(12):2537-2548.
Eylea [package insert]. Tarrytown, NY: Regeneron Pharmaceuticals, Inc; 2019.
Eylea [package insert]. Tarrytown, NY: Regeneron Pharmaceuticals, Inc; 2019.
Schmidt-Erfurth U, et al. Ophthalmology. 2014;121:193-201.
Schmidt-Erfurth U, et al. Ophthalmology. 2014;121:193-201.
The information contained in this section of the site is intended for U.S. healthcare professionals only. Click "OK" if you are a healthcare professional.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.